Position in INO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$219,447
-$75,671 QoQ
Shares Held
126,119
0.0% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GMT Capital Corp holds $123,541,469 across 6 Biotechnology names. INO ranks #6 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
581,000 | $109,838,050 | |
| 2 | OCGN |
Ocugen, Inc.
|
3,505,398 | $6,344,770 | |
| 3 | TRVI |
Trevi Therapeutics, Inc.
|
317,700 | $3,790,161 | |
| 4 | PGEN |
Precigen, Inc.
|
668,830 | $2,588,372 | |
| 5 | FLNA |
Filana Therapeutics, Inc.
|
450,100 | $760,669 | |
| 6 | INO |
Inovio Pharmaceuticals, Inc.
This page
|
126,119 | $219,447 |
All Filings in INO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $219,447 | 126,119 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $295,118 | 126,119 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $257,282 | 126,119 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $205,573 | 126,119 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $230,801 | 126,121 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $728,979 | 126,121 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||